149 related articles for article (PubMed ID: 7620171)
1. HLA associations in clozapine-induced agranulocytosis.
Yunis JJ; Corzo D; Salazar M; Lieberman JA; Howard A; Yunis EJ
Blood; 1995 Aug; 86(3):1177-83. PubMed ID: 7620171
[TBL] [Abstract][Full Text] [Related]
2. The major histocompatibility complex region marked by HSP70-1 and HSP70-2 variants is associated with clozapine-induced agranulocytosis in two different ethnic groups.
Corzo D; Yunis JJ; Salazar M; Lieberman JA; Howard A; Awdeh Z; Alper CA; Yunis EJ
Blood; 1995 Nov; 86(10):3835-40. PubMed ID: 7579351
[TBL] [Abstract][Full Text] [Related]
3. HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia.
Lieberman JA; Yunis J; Egea E; Canoso RT; Kane JM; Yunis EJ
Arch Gen Psychiatry; 1990 Oct; 47(10):945-8. PubMed ID: 2222133
[TBL] [Abstract][Full Text] [Related]
4. HSP70-2 9.0 kb variant is in linkage disequilibrium with the HLA-B and DRB1* alleles associated with clozapine-induced agranulocytosis.
Corzo D; Yunis JJ; Yunis EJ; Howard A; Lieberman JA
J Clin Psychiatry; 1994 Sep; 55 Suppl B():149-52. PubMed ID: 7961560
[TBL] [Abstract][Full Text] [Related]
5. HLA-B38 and clozapine-induced agranulocytosis in Israeli Jewish schizophrenic patients.
Valevski A; Klein T; Gazit E; Meged S; Stein D; Elizur A; Narinsky ER; Kutzuk D; Weizman A
Eur J Immunogenet; 1998 Feb; 25(1):11-3. PubMed ID: 9587740
[TBL] [Abstract][Full Text] [Related]
6. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews.
Kwon OJ; Karni A; Israel S; Brautbar C; Amar A; Meiner Z; Abramsky O; Karussis D
Arch Neurol; 1999 May; 56(5):555-60. PubMed ID: 10328250
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex associations with clozapine-induced agranulocytosis. The USA experience.
Yunis JJ; Lieberman J; Yunis EJ
Drug Saf; 1992; 7 Suppl 1():7-9. PubMed ID: 1503679
[TBL] [Abstract][Full Text] [Related]
8. Immunogenetics of HLA class II in Israeli Ashkenazi Jewish, Israeli non-Ashkenazi Jewish, and in Israeli Arab IDDM patients.
Kwon OJ; Brautbar C; Weintrob N; Sprecher E; Saphirman C; Bloch K; Pinhas-Hamiel O; Assah S; Vardi P; Israel S
Hum Immunol; 2001 Jan; 62(1):85-91. PubMed ID: 11165718
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
[TBL] [Abstract][Full Text] [Related]
10. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients.
Hodak E; Lapidoth M; Kohn K; David D; Brautbar B; Kfir K; Narinski N; Safirman S; Maron M; Klein K
Br J Dermatol; 2001 Dec; 145(6):974-80. PubMed ID: 11899152
[TBL] [Abstract][Full Text] [Related]
11. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
[TBL] [Abstract][Full Text] [Related]
12. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of HLA allelic frequencies and haplotypes in Jordanians and comparison with other related populations.
Sánchez-Velasco P; Karadsheh NS; García-Martín A; Ruíz de Alegría C; Leyva-Cobián F
Hum Immunol; 2001 Sep; 62(9):901-9. PubMed ID: 11543892
[TBL] [Abstract][Full Text] [Related]
14. Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris.
Ahmed AR; Wagner R; Khatri K; Notani G; Awdeh Z; Alper CA; Yunis EJ
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):5056-60. PubMed ID: 1675792
[TBL] [Abstract][Full Text] [Related]
15. HLA polymorphism in a Majorcan population of Jewish descent: comparison with Majorca, Minorca, Ibiza (Balearic Islands) and other Jewish communities.
Crespí C; Milà J; Martínez-Pomar N; Etxagibel A; Muñoz-Saa I; Priego D; Luque A; Pons J; Picornell A; Ramon M; Castro JA; Matamoros N
Tissue Antigens; 2002 Oct; 60(4):282-91. PubMed ID: 12472657
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups.
Turbay D; Lieberman J; Alper CA; Delgado JC; Corzo D; Yunis JJ; Yunis EJ
Blood; 1997 Jun; 89(11):4167-74. PubMed ID: 9166860
[TBL] [Abstract][Full Text] [Related]
17. HLA class II immunogenetics of IDDM in Yemenite Jews.
Israel S; Kwon OJ; Weintrob N; Sprecher E; Bloch K; Assa S; Brautbar C; Vardi P
Hum Immunol; 1998 Nov; 59(11):728-33. PubMed ID: 9796741
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR2 haplotypic diversity in populations of South-East Asia, northern China, Melanesia and Australian aborigines using PCR-RFLP for DRB1, DRB5, DQA1 and DQB1. A novel DRB1 allele: DRB1*16022.
Trejaut J; Bhatia K; Greville WD; Hu KR; Duraisamy G; Nuchprayoon C; Donald J; Aziz A; Dunckley H
Eur J Immunogenet; 1996 Dec; 23(6):437-49. PubMed ID: 8971541
[TBL] [Abstract][Full Text] [Related]
19. Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris: possible common central Asian ancestral origin.
Mobini N; Yunis EJ; Alper CA; Yunis JJ; Delgado JC; Yunis DE; Firooz A; Dowlati Y; Bahar K; Gregersen PK; Ahmed AR
Hum Immunol; 1997 Sep; 57(1):62-7. PubMed ID: 9438197
[TBL] [Abstract][Full Text] [Related]
20. Human leukocyte antigen system in clozapine-induced agranulocytosis.
Theodoropoulou S; Pappa H; Lykouras L; Papageorgiou G; Papasteriades C; Sakalis G
Neuropsychobiology; 1997; 36(1):5-7. PubMed ID: 9211436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
